U.S. stocks related to weight loss drugs generally fell on Tuesday, with Novo Nordisk ADR experiencing the largest decline, down 14.64%. Other companies such as ShouTi Bio, GoodRx, and Eli Lilly also saw varying degrees of decline, resulting in poor overall market performanceWallstreetcn·Feb 3 at 09:09 PMLLY-0.65%NVO-2.14%
GoodRx rose 37%, marking its best single-day performance since September 2020Wallstreetcn·Aug 18, 2025 at 08:01 PMGDRX+1.19%
